Pack identified
The strength per vial and the reference box size are recorded from the brochure.
500 mg; reference box of 10
Brochure photograph 1 / 2Leave your number and we will let you know when the vial arrives.
A 500 mg lyophilized NAD+ vial introduced by South Korea's Vita Medical. On the way; leave a mobile number to hear when it arrives.
Overview, evidence, specifications and essential warnings — short and in one place.

The brochure identifies a RejuvaNAD+ vial with 500 mg of NAD+. You can review the stated pack facts and register for an arrival alert. Before any supply, the exact name, batch, cold chain, label and authorised use need to match the delivered product.
Product specifications are kept separate from cosmetic and medical claims.
The strength per vial and the reference box size are recorded from the brochure.
500 mg; reference box of 10The refrigerator range is documented and will be checked against the delivered batch.
2–8°COnly arrival notification is open while product checks continue.
Coming soonThis is guidance for an informed evaluation; it is not a guarantee of results or a substitute for a physician's advice and the product label.
The supplied RejuvaNAD+ brochure describes a lyophilized vial containing 500 mg of nicotinamide adenine dinucleotide. Its reference box contains 10 vials, with refrigerated storage at 2–8°C. This page introduces the pack and collects arrival alerts. The delivered label, batch, authorisation and supply conditions must be checked before any sale.
Official data, buyer reviews and questions are kept clearly separate.
The supplied brochure calls it RejuvaNAD+; Vita Medical's current page calls it RejuvaNAD+ Pro. Both describe a 500 mg lyophilized NAD+ vial, a 10-vial reference box and 2–8°C storage. The exact delivered pack will be checked. Preclinical and modelled findings in the brochure do not establish clinical outcomes in humans.
View the official product page